Metabolomic Signatures of Physical Function and Functional Trajectories in Older Adults: Insights from the ENRGISE Clinical Trial
Open Access
- 22 December 2025
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 16 (1) , 9
Abstract
Background: Chronic inflammation contributes to functional decline in older adults, yet interventions targeting inflammatory pathways have shown inconsistent results. Metabolomics offers a promising approach to identify biological heterogeneity and uncover molecular signatures underlying differential functional trajectories. Objective: Our objective was to examine whether untargeted serum metabolomics can identify metabolic signatures associated with baseline physical function, functional trajectories, and treatment response in older adults with chronic inflammation participating in the ENRGISE trial. Methods: We performed untargeted metabolomic profiling on serum samples (n = 731) collected at baseline, 6, and 12 months from participants (mean age ≥ 70) enrolled in the ENRGISE pilot randomized trial. Participants were randomized to losartan, omega-3 supplementation, both, or placebo. Functional measures included grip strength and 400 m gait speed. Group-based trajectory modeling classified participants into functional trajectories over 12 months. Partial least squares-discriminant analysis (PLS-DA) and pathway enrichment (mummichog algorithm) were used to identify differentially abundant metabolites and perturbed pathways. Results: Baseline metabolomic profiles differed by physical function status. Participants with low grip strength showed enrichment in vitamin A metabolism pathways, while slower gait speed was associated with higher levels of prostaglandin and eicosanoid metabolites. Baseline metabolic profiles distinguished individuals who later declined versus improved in functional performance. Omega-3 supplementation, but not losartan, induced distinct changes in lipid-related pathways, including fatty acid activation, omega-3 metabolism, and prostaglandin biosynthesis, indicating that individuals responded to these interventions metabolically despite null clinical outcomes. Conclusions: Serum metabolomic signatures were associated with baseline physical function, predicted functional trajectories, and revealed pharmacologic activity of omega-3 supplementation. These findings support the use of metabolomics to uncover biological heterogeneity and inform precision geroscience strategies in aging populations.Keywords
Funding Information
- Clin-STAR Coordinating Center (CS22005)
This publication has 38 references indexed in Scilit:
- Energy Metabolism and Brain Aging: Strategies to Delay Neuronal DegenerationCellular and Molecular Neurobiology, 2025
- Multi-omics research in sarcopenia: Current progress and future prospectsAgeing Research Reviews, 2022
- Sarcopenic metabolomic profile reflected a sarcopenic phenotype associated with amino acid and essential fatty acid changesMetabolomics, 2021
- Prevalence of Hospital-Associated Disability in Older Adults: A Meta-analysisJournal of the American Medical Directors Association, 2020
- The metabolomics side of frailty: Toward personalized medicine for the agedExperimental Gerontology, 2019
- Functional genomics applications and therapeutic implications in sarcopeniaMutation Research - Reviews in Mutation Research, 2019
- Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysisAgeing Research Reviews, 2018
- Grip strength and mortality: a biomarker of ageing?The Lancet, 2015
- Geroscience: Linking Aging to Chronic DiseaseCell, 2014
- Analyzing developmental trajectories of distinct but related behaviors: A group-based method.Psychological Methods, 2001